Depot Naltrexone Treatment of Opioid Dependent Parolees
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This is an investigation involving the use of a long-acting, injectable form (depot) of
naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40
on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects
treated with 6 months of depot naltrexone plus Psychosocial Treatment .